Vistagen Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Vistagen Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2024 was $88K, a 89.9% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $128M.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.04M, a 110% decline from 2021.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $10.5M, a 90.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $128M +$129M Apr 1, 2023 Mar 31, 2024 10-K 2024-06-11
2022 -$1.04M -$11.5M -110% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 $10.5M -$104M -90.8% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 $114M +$110M +2744% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $4.01M -$13.4M -77% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-29
2018 $17.4M +$907K +5.49% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 $16.5M Apr 1, 2017 Mar 31, 2018 10-K 2019-06-25
2014 $2.84M +$1.34M +89.6% Apr 1, 2014 Mar 31, 2015 10-K 2015-06-29
2013 $1.5M -$2.66M -64% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 $4.16M +$616K +17.4% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-25
2011 $3.54M +$2.7M +323% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 $837K Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.